Dacocent

药品简介

Originator: VIZIMPRO by Pfizer · Manufacturer: Incepta Pharma. Indication & Dosage: Dacocent (Dacomitinib), generic Vizimpro is a prescription medicine used to treat in patients with advanced non-small cell lung cancer (NSCLC). Dacomitinib is a highly effective for the treatment of rare EGFR gene mutations. Dacomitinib can be used as a replacement medicine for Afatinib after the treatment of the disease progresses. Dacocent manufactured by Incepta Pharma Ltd. In Bangladesh. Dacomitinib has to take orally once a day with or without food until the disease progresses or irreversible toxicity occurs. Side Effects: The most common side effects of Dacomitinib are: Rash , diarrhea , hair loss , mouth pain and sores, nail inflammation, decreased weight dry, common cold, dry skin, decreased appetite, red, itchy eyes, itching. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。